Crescent Biopharma, Inc. (CBIO)
13.06
+0.70
(+5.66%)
USD |
NASDAQ |
Oct 20, 16:00
13.06
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma EPS Diluted (Quarterly) : -0.8135 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8135 |
| March 31, 2026 | -0.7659 |
| December 31, 2025 | -4.581 |
| September 30, 2025 | -1.488 |
| June 30, 2025 | -5.650 |
| March 31, 2025 | -19.63 |
| December 31, 2024 | -11.20 |
| September 30, 2024 | -15.24 |
| June 30, 2024 | -15.66 |
| March 31, 2024 | -16.66 |
| December 31, 2023 | -14.10 |
| September 30, 2023 | -14.30 |
| June 30, 2023 | -12.85 |
| March 31, 2023 | -17.16 |
| December 31, 2022 | -19.34 |
| September 30, 2022 | -16.26 |
| June 30, 2022 | -25.32 |
| March 31, 2022 | -28.00 |
| December 31, 2021 | -33.50 |
| September 30, 2021 | -33.61 |
| June 30, 2021 | -27.94 |
| March 31, 2021 | -28.16 |
| December 31, 2020 | -32.43 |
| September 30, 2020 | -28.88 |
| June 30, 2020 | -32.14 |
| Date | Value |
|---|---|
| March 31, 2020 | -17.58 |
| December 31, 2019 | -33.95 |
| September 30, 2019 | -30.61 |
| June 30, 2019 | -36.66 |
| March 31, 2019 | -32.63 |
| December 31, 2018 | -32.23 |
| September 30, 2018 | -26.88 |
| June 30, 2018 | -26.35 |
| March 31, 2018 | -32.75 |
| December 31, 2017 | -27.00 |
| September 30, 2017 | -24.00 |
| June 30, 2017 | -30.00 |
| March 31, 2017 | -34.00 |
| December 31, 2016 | -36.00 |
| September 30, 2016 | -34.00 |
| June 30, 2016 | -41.00 |
| March 31, 2016 | -40.00 |
| December 31, 2015 | -47.00 |
| September 30, 2015 | -38.00 |
| June 30, 2015 | 51.00 |
| March 31, 2015 | -37.00 |
| December 31, 2014 | -39.00 |
| September 30, 2014 | -35.00 |
| June 30, 2014 | 39.00 |
| March 31, 2014 | -27.16 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Encompass Health Corp. | 1.539 |
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -2.431 |
| Marijuana, Inc. | -0.0046 |
| Veltex Corp. | -0.0028 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.84M |
| Total Expenses (Quarterly) | 24.84M |
| Enterprise Value | 176.91M |
| Earnings Yield | -58.56% |
| Normalized Earnings Yield | -58.56 |